Glucokinase Activator for GCK-MODY Diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an experimental pill (a glucokinase activator) in adults with a specific genetic form of diabetes called GCK-MODY. The study aims to see if the pill can help control blood sugar without causing dangerously low sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have a confirmed genetic change (mutation) in the GCK gene that causes GCK-MODY.
- Your BMI is between 18 and 30.
- Your fasting blood sugar is above 5.6 mmol/L at screening.
- You have not taken certain diabetes medications in the last 6 weeks (like sulfonylureas, insulin, or GLP-1 agonists).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new drug called dorzagliatin to see how it affects insulin and other hormones that control blood sugar in people with prediabetes or type 2 diabetes. It may help improve how your body handles sugar.
This study tests a new oral medication, dorzagliatin, to see if it can improve blood sugar control in people with type 2 diabetes and moderate to severe kidney disease. Participants must be on a stable basal insulin regimen with or without certain oral diabetes drugs.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This trial tests whether liraglutide, a once-daily injection, helps manage blood sugar in people with MODY diabetes. It's for those with high A1c levels and no prior use of similar drugs or certain health conditions.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.